文献速递胃肠动力与功能性疾病

罗马IV标准与罗马III标准在二级医疗中诊断肠易激综合征的比较

Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
PubMed 文献 · Gut · 2020-09-24

本研究在单一英国诊所连续纳入疑似肠易激综合征(IBS)成人患者,比较罗马IV与罗马III标准的诊断效能。罗马IV标准灵敏度82.4%、特异度82.9%,罗马III标准灵敏度85.8%、特异度65.0%。罗马IV标准在此单中心二级医疗研究中显著优于罗马III标准,但临床意义不确定。

要点

  • 罗马IV与罗马III标准间一致性良好(kappa=0.65)。
  • 572例中罗马IV标准灵敏度82.4%、特异度82.9%,阳性似然比4.82、阴性似然比0.21。
  • 471例中罗马III标准灵敏度85.8%、特异度65.0%,阳性似然比2.45、阴性似然比0.22。

核心结论

  • 在此单中心二级医疗研究中,罗马IV标准诊断IBS显著优于罗马III标准,但其临床意义不确定。

研究设计与样本

  • 收集连续转诊至单一英国诊所的疑似IBS成人患者的完整症状数据,所有受试者接受相对标准化的检查,评估者对症状状态设盲。
  • 以检查后无器质性胃肠病证据的患者存在下腹痛或不适伴大便性状或频率改变为参考标准。
  • 计算各诊断标准的灵敏度、特异度及阳性与阴性似然比(LRs)及其95%CI。

主要发现

  • 罗马IV与罗马III标准间一致性良好(kappa=0.65)。
  • 572例患者(431例(75.3%)女性,平均年龄36.5岁)中,罗马IV标准灵敏度82.4%、特异度82.9%,阳性LR 4.82(95%CI 3.30至7.28),阴性LR 0.21(95%CI 0.17至0.26)。
  • 罗马IV标准在便秘型或混合型IBS患者中表现最佳。
  • 471例患者(350例(74.3%)女性,平均年龄36.7岁)中,罗马III标准灵敏度85.8%、特异度65.0%,阳性LR 2.45(95%CI 1.90至3.27),阴性LR 0.22(95%CI 0.16至0.29)。
  • 将情绪及肠外症状报告纳入诊断标准未显著改善其表现。

关键数值与推荐

  • 罗马IV标准:灵敏度82.4%、特异度82.9%、阳性LR 4.82(95%CI 3.30至7.28)、阴性LR 0.21(95%CI 0.17至0.26)。
  • 罗马III标准:灵敏度85.8%、特异度65.0%、阳性LR 2.45(95%CI 1.90至3.27)、阴性LR 0.22(95%CI 0.16至0.29)。
  • 罗马IV与罗马III标准间一致性kappa=0.65。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出该研究为单中心二级医疗研究,罗马IV标准虽显著优于罗马III标准,但其临床意义不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Despite being proposed 4 years ago, there has been no independent validation study of the Rome IV criteria for IBS. We assessed their performance for the diagnosis of IBS in secondary care and compared them with the previous iteration, the Rome III criteria. DESIGN: We collected complete symptom data from consecutive adult patients with suspected IBS referred to a single UK clinic. All subjects underwent relatively standardised workup, with assessors blinded to symptom status. The reference standard used to confirm IBS was the presence of lower abdominal pain or discomfort in association with altered stool form or frequency, in a patient with no evidence of organic gastrointestinal disease after investigation. Sensitivity, specificity and positive and negative likelihood ratios (LRs), with 95% CIs, were calculated for each of the diagnostic criteria. RESULTS: The level of agreement between the Rome IV and Rome III criteria was good (kappa=0.65). Compared with the reference standard, sensitivity and specificity of the Rome IV criteria in 572 patients (431 (75.3%) women, mean age 36.5 years) were 82.4% and 82.9%, respectively. Positive and negative LRs for the Rome IV criteria were 4.82 (95% CI 3.30 to 7.28) and 0.21 (95% CI 0.17 to 0.26), respectively. The Rome IV criteria performed best in those with IBS with constipation or mixed bowel habits. In 471 patients (350 (74.3%) women, mean age 36.7 years), compared with the reference standard, the sensitivity and specificity of the Rome III criteria were 85.8% and 65.0%; positive and negative LRs were 2.45 (95% CI 1.90 to 3.27) and 0.22 (0.16 to 0.29), respectively. Incorporating mood and extraintestinal symptom reporting into diagnostic criteria did not improve their performance significantly. CONCLUSIONS: The Rome IV criteria performed significantly better than the Rome III criteria in diagnosing IBS in this single centre secondary care study, although the clinical relevance of this is uncertain.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Black CJ, Craig O, Gracie DJ, et al. Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gut. 2020. PMID: 32973070. doi:10.1136/gutjnl-2020-322519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。